Synthesis of a piceatannol analog: Replacement of hydroxy group with amide functionality

Synthetic Communications

Volumn 34, Issue 8, 2004, Pages 1489-1497

  Venkatachalam, T K ^a   Huang, H ^a   Yu, G ^a   Uckun, F M ^a,b  

^a PARKER HUGHES INSTITUTE   (United States)

^b Parker Hughes Cancer Center   (United States)

Author keywords

Amido group; Piceatannol; Protein tyrosine kinase; Stilbene derivatives

Indexed keywords

AMIDE; PICEATANNOL DERIVATIVE; PROTEIN TYROSINE KINASE; STILBENE DERIVATIVE; UNCLASSIFIED DRUG;

AMIDATION; ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; PROTON NUCLEAR MAGNETIC RESONANCE; REACTION ANALYSIS; SYNTHESIS;

EID: 2442689080     PISSN: 00397911     EISSN: None     Source Type: Journal    
DOI: 10.1081/SCC-120030700     Document Type: Article

References (12)

1. Burke, T.R. Protein-tyrosine kinase inhibitors. Drug. Future 1992, 17 (2), 119-131.
2. Chang, C.J.; Geahlen, R.L. Protein-tyrosine kinase inhibition: mechanism-based discovery of antitumor agents. J..Nat. Prod. 1992, 55 (11), 1529-1560.
3. Dobrusin, E.M.; Fry, D.W. In Annual Reports in Medicinal Chemistry; Bristol, J.A., Ed.; Academic Press: San Diego, CA, 1992; 169-178.
4. Levitzki, A. Tyrphostins: tyrosine kinase blockers as novel antiproliferative agents and dissectors of signal transduction. Faseb J. 1992, 6 (14), 3275-3282.
5. Bajaj, R.; Gill, M.T.; Mclaughlin, J.L. Rev. Latinoamer Quinn 1987, 18, 79-80.
6. Reimann, E. Natürliche polyhydroxystilbene. Die synthese von oxyresveratrol, piceatannol und rhapontigenin. Tetrahedron Lett. 1970, 11 (47), 4051-4053.
7. Thakkar, K.; Geahlen, R.L.; Cushman, M. Synthesis and protein-tyrosine kinase inhibitory activity of polyhydroxylated stilbene analogues of piceatannol. J. Med. Chem. 1993, 36 (20), 2950-2955.
8. Smyth, M.S.; Stefanova, I.; Hartmann, F.; Horak, I.D.; Osherov, N.; Levitzki, A.; Burke, T.R., Jr. Non-amine based analogues of lavendustin A as protein-tyrosine kinase inhibitors. J. Med. Chem. 1993, 36 (20), 3010-3014.
9. Yamada, K.; Ikezaki, M.; Umino, N.; Ohtsuka, H.; Itoh, N.; Ikezawa, K.; Kiyomoto, A.; Iwakuma, T. Studies on 1,2,3,4-tetrahydroisoquinoline derivatives. I. Syntheses and beta-adrenoceptor activities of positional isomers of trimetoquinol with respect to its 6,7-dihydroxyl groups. Chem. Pharm. Bull. (Tokyo) 1981, 29 (3), 744-753.
10. Uckun, F.M.; Waddick, K.G.; Mahajan, S.; Jun, X.; Takata, M.; Bolen, J.; Kurosaki, T. BTK as a mediator of radiation-induced apoptosis in DT-40 lymphoma B cells. Science 1996, 273 (5278), 1096-1100.
11. Uckun, F.M.; Evans, W.E.; Forsyth, C.J.; Waddick, K.G.; Ahlgren, L.T.; Chelstrom, L.M.; Burkhardt, A.; Bolen, J.; Myers, D.E. Biotherapy of B-cell precursor leukemia by targeting genistein to CD19-associated tyrosine kinases. Science 1995, 267 (5199), 886-891.
12. Uckun, F.M.; Narla, R.K.; Jun, X.; Zeren, T.; Venkatachalam, T.; Waddick, K.G.; Rostostev, A.; Myers, D.E. Cytotoxic activity of epidermal growth factor-genistein against breast cancer cells. Clin. Cancer Res. 1998, 4 (4), 901-912.